Healthcare -
Biotechnology - NASDAQ - US
$ 20.35
1.67 %
$ 1.54 B
Market Cap
-7.07
P/E
NRIX - STOCK-BASED COMPENSATION
Stock-based Compensation NRIX - Nurix Therapeutics, Inc.
33.7 M
LAST VALUE
45.99%
2 YEAR CAGR
139.09%
5 YEAR CAGR
0.00%
10 YEAR CAGR